Any question on childhood cancer?
The purpose of the Leucan Information Centre is to provide information to pediatric cancer patients and their parents.
31 January 2023
ertain brain cells may be inherently vulnerable to the kinds of mutations that cause fatal brain tumours in children and young adults, says a study whose international research team was co-led by a principal investigator at the Lady Davis Institute (LDI). The findings, recently published in the journal Nature Genetics, represent a significant advance in understanding the development of tumours known as high-grade gliomas. This could be significant in the design of clinical trials for new types of therapy.
16 January 2023
A Montreal research team, headed by the eminent Janusz Rak, Ph.D., continues to lead the way to the ‘next frontier’ in pediatric cancer screening, diagnosis, and treatment thanks to the support of visionary partners of The Children’s Foundation.
03 November 2022
The Initiative will accelerate the development of platforms, tools and treatments to support advancements across all areas of pediatric cancer care: prevention, diagnosis and treatment.
20 October 2022
Nanopores and precision medicine: A quasi-instantaneous diagnosis to accelerate leukemia patient management
Chartré, Marie-Eve, Johanne Gagné et Vanessa Destrempes
Quebec, 2022
Leroux, Sophie
Quebec, 2022
Bordeleau, Nicole
Quebec, 2020
Warning: Leucan Information Centre staff members do not possess medical, paramedical or psychosocial expertise. All information sources provided by the Leucan Information Centre are of a general nature and are complementary to the information already supplied by healthcare professionals. It is advisable that you address all of your specific, medical questions to these specialists. Leucan nor CHU Sainte-Justine do not endorse or accept any responsibility for contents supplied by the Leucan Information Centre.